Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00611585 · ClinicalTrials.gov registry record · NA
A Safety and Efficacy Study of the Birmingham Hip Resurfacing System
A NA study of Arthritis, sponsored by Smith & Nephew.
- Completed
- Registry status
- NA
- Development phase
- 360
- Enrollment target
- 7
- Study locations
NCT00611585: Completed NA study of Arthritis, sponsored by Smith & Nephew.
NCT00611585 is a NA study of Arthritis that has completed, run by Smith & Nephew. The registered enrollment target is 360 participants, below the 4,503-participant average among 48 other Arthritis trials with a reported enrollment target (92% lower). The trial reports 7 study locations across 6 states. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00611585, a NA study of Arthritis, has completed, sponsored by Smith & Nephew.
- COMPLETED
- Registry status
- NA
- Development phase
- 360 participants
- Enrollment target
- 7
- Study locations
Study Summary
The purpose of this study is to meet a PMA condition of approval of the BHR System. The study will evaluate the long term safety and effectiveness of the BHR system in patients with non-inflammatory and inflammatory arthritis.
Primary Outcome
Proportion of participants with revision by 10 years. A revision was defined as removal with or without replacement of the components (device revision may have been partial or total).
Conditions Studied
Interventions
- DEVICE Birmingham Hip Resurfacing
Study Locations (7)
New York
- Hospital for Special Surgery - New York
- University of Rochester Medical Center - Rochester
Arizona
- Tucson Orthopaedic Institute - Tucson
Louisiana
- Center for Orthopaedics - Lake Charles
North Carolina
- OrthoCarolina - Charlotte
Virginia
- Anderson Orthopaedic Clinic - Alexandria
Wisconsin
- Aurora Medical Center - Grafton
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 360 participants |
| Start Date | 2006-09 |
| Est. Completion | 2025-05-12 |
| Phase | NA |
What the finished NCT00611585 record still lists
NCT00611585 is an interventional study that assigns participants to a tested intervention. The registered 360 participants enrollment target is mid-sized for trials with a published cap, below the 4,503-participant average among 48 other Arthritis trials with a reported enrollment target (92% lower).
The record links to 1 condition, with Arthritis appearing as the primary indexed condition, and to 1 intervention - of which Birmingham Hip Resurfacing is the first listed.
NCT00611585 lists 7 locations in 6 states (New York, Arizona, Louisiana).
Frequently Asked Questions
What is clinical trial NCT00611585 about?
NCT00611585 is a clinical study titled "A Safety and Efficacy Study of the Birmingham Hip Resurfacing System". The purpose of this study is to meet a PMA condition of approval of the BHR System. The study will evaluate the long term safety and effectiveness of the BHR system in patients with non-inflammatory and inflammatory arthritis.
What is the current status of trial NCT00611585?
This trial is currently completed. It is a NA study. The enrollment target is 360 participants. The study started on 2006-09. Estimated completion is 2025-05-12.
What conditions does trial NCT00611585 study?
This clinical trial studies the following conditions: Arthritis.
What interventions are being tested in trial NCT00611585?
The interventions under investigation include: Birmingham Hip Resurfacing (DEVICE).
Who is sponsoring clinical trial NCT00611585?
This trial is sponsored by Smith & Nephew, which has 72 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT00611585 being conducted?
This trial has 7 study locations across Arizona, Louisiana, New York, North Carolina, Virginia. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Arthritis
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT00611585's enrollment target sits among peer trials
360 14th of 48 higher than 34 of 48 other Arthritis trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Arthritis trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Expanding Exercise Programming for Veterans Through Telehealth
RECRUITING · NA
-
Dose Response of Exercise for Arthritis Management
RECRUITING · NA
-
Aptis PRUJ Prosthesis for the Treatment of Patients With Proximal Radial Ulna Joint Disorders.
RECRUITING · NA
-
Geniculate Artery Embolization for Osteoarthritis
RECRUITING · NA
-
Impact of Biophoton Therapy on Chronic Severe Arthritis Pain
RECRUITING · NA
-
Comparing Functional Outcomes in Individuals Using Micro-processor Controlled Orthosis Versus Stance Control Orthosis
ACTIVE NOT RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02747836 · 360 participants
Ultrasound Analysis of Human Carpal Tunnel System
- NCT04089046 · 360 participants · NA
Telemedicine Enhanced Asthma Management - Uniting Providers for Teens (TEAM-UP for Teens)
- NCT04130503 · 360 participants · NA
The Recovery in Stroke Using PAP Study
- NCT04160000 · 360 participants · Phase 4
Treatment Of Atrial Fibrillation In Preserved Cardiac Function Heart Failure
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia